AMG
41
3
PRU
59
5
PBI
68
3
EW
29
2
STT
67
3
DE
40
4
ACN
49
2
CHD
50
2
KSS
46
7
MAT
51
-4
AAP
39
7
JNPR
54
-2
FDX
44
-7
BAX
35
-3
ADT
58
-3
LUV
48
3
EXPD
40
-3
PM
54
-2
MET
63
3
ROP
62
-3
AMG
41
3
PRU
59
5
PBI
68
3
EW
29
2
STT
67
3
DE
40
4
ACN
49
2
CHD
50
2
KSS
46
7
MAT
51
-4
AAP
39
7
JNPR
54
-2
FDX
44
-7
BAX
35
-3
ADT
58
-3
LUV
48
3
EXPD
40
-3
PM
54
-2
MET
63
3
ROP
62
-3
Financhill
Back

Tango Therapeutics Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Sell
20

TNGX
Tango Therapeutics

Last Price:
3.38
Seasonality Move:
3.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Tango Therapeutics Price Quote

$3.38

Tango Therapeutics Key Stats

Sell
20
Tango Therapeutics (TNGX) is a Sell
Day range:
$2.70 - $3.41
52-week range:
$2.70 - $13.01
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.37
P/B ratio:
1.58%
Volume:
4.4M
Avg. volume:
2.1M
1-year change:
-59.57%
Market cap:
$363.1M
Revenue:
$36.5M
EPS:
$-1.16

How Much Does Tango Therapeutics Make?

Is Tango Therapeutics Growing As A Company?

  • What Is Tango Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.08%
  • What Is Tango Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Tango Therapeutics Stock Price Performance

What Is Tango Therapeutics 52-Week High & Low?

Tango Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Tango Therapeutics?

Is Tango Therapeutics Cash Flow Positive?

  • What Is TNGX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$122.3M
  • What Is Tango Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $48.2M
  • What Is Tango Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $67.9M

Tango Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TNGX return on invested capital is -48.54%
  • What Is Tango Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -31.31%
  • What Is TNGX Return On Equity?
    ROE is a measure of profitability and is -48.54%

Tango Therapeutics Earnings Date & Stock Price

Tango Therapeutics Competitors

Tango Therapeutics Dividend Yield

Tango Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 27.94%
Revenue: 8.15% 43.9%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 11.50
Upside from Last Price: 240.24%

Major Shareholders

  • How many TNGX shares are owned by institutional investors?
    158.6M TNGX shares are owned by institutional investors
  • How many TNGX shares are owned by insiders?
    2.1M TNGX shares are owned by insiders